Celiac disease researcher nabs top international prize

Celiac disease researcher nabs top international prize

Advances University of Chicago Celiac Disease Center fight against world's most common autoimmune disease

May 7, 2010

Bana Jabri, MD, PhD, co-director, University of Chicago Digestive Disease Research Core Center, and an internationally renowned celiac disease researcher, was recently awarded the coveted Warren Prize for Excellence in Celiac Disease Research.

Presented annually by The William K. Warren Foundation, the $25,000 award goes to an individual or group whose research is judged by an independent committee of scientific experts to have made a significant contribution to the field of celiac disease research by way of basic, translational, and/or clinical research.

The Warren Foundation this year elected to make two separate full awards due to the significant contributions two recipients have made to the field. Jabri received the award for excellence in basic research.

Nominations are open to individuals from the United States and abroad. This marks the first time the award has been given to a researcher in the United States, as well as the first time a female research has received this high honor.

Jabri's groundbreaking work includes the development of the first-ever mouse model to find a vaccine and cure for celiac disease. Her team of researchers has introduced several genetic modifications leading to the loss of tolerance to gluten in mice. Now Jabri is leading the effort to create a celiac mouse model reproducing the human disease, a critical breakthrough in celiac research. "It would have a profound impact on the future of celiac disease," said Jabri. "It would not only allow us to better understand the pathogenesis of celiac disease, but to develop and test new therapeutic avenues."

Celiac disease is triggered by the ingestion of gluten, the protein found in wheat, barley and rye by genetically predisposed individuals. Although often discounted as a manageable chronic health condition, left untreated celiac disease can be fatal. There is no cure for celiac disease; the sole treatment remains lifelong adherence to a strict gluten-free diet.

At least 3 million Americans suffer with celiac disease. That number is on the rise; there has been a four-fold increase in the prevalence of celiac disease over the last 50 years.
"The Warren Prize is well deserved," said Stefano Guandalini, MD, founder and medical director of The University of Chicago Celiac Disease Center. "We are honored to have such a stellar researcher leading our team. With the proper funding, I am confident Dr. Jabri will lead us to the cure for celiac disease."

An associate professor in the departments of Medicine, Pathology and Pediatrics at the University of Chicago Medical Center, Jabri is also a member of the Committee on Immunology.

"This year was special in that two individuals tied for first place," said Martin F. Kagnoff, MD, director, Wm. K. Warren Celiac Center. "One award is for excellence in basic research and one for outstanding contributions in the area of clinical/translational research. Dr. Jabri was selected from among a large number of candidates to receive this prestigious award."